Wednesday, 30 January 2019

Novel Combined Oral Contraceptive Effective in Phase 3 Trial - Monthly Prescribing Reference

Novel Combined Oral Contraceptive Effective in Phase 3 Trial  Monthly Prescribing Reference

Mithra announced that the Phase 3 Estelle study met its primary efficacy endpoint, demonstrating "excellent contraceptive efficacy" in line with similar approved ...

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)